Sculptor Capital LP Crispr Therapeutics Ag Transaction History

Sculptor Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$40.99 - $52.56 $229,544 - $294,336	-5,600 Reduced 6.8%	76,700 $3.14 Million
Q2 2019 Aug 16, 2019	BUY	$35.45 - $48.2 $2.92 Million - $3.97 Million	82,300 New	82,300 $0
Q2 2019 Aug 14, 2019	SELL	$35.45 - $48.2 $2.92 Million - $3.97 Million	-82,300 Closed	0 $0
Q1 2019 Mar 16, 2021	BUY	$28.02 - $40.87 $2.31 Million - $3.36 Million	82,300 New	82,300 $2.94 Million

499

56.8M

1.7M

1.8M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.05B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

Stay updated on Sculptor Capital LP with notifications on news.